Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

Clinical trial NCT04839354 · COMPLETED

Trial details

NCT number: NCT04839354
Sponsor: Claudia R. Morris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2021-06-21
Primary completion: 2024-07-11
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.